Subthalamic 85 Hz deep brain stimulation improves walking pace and stride length in Parkinson’s disease patients
-
Published:2023-08-10
Issue:1
Volume:5
Page:
-
ISSN:2524-3489
-
Container-title:Neurological Research and Practice
-
language:en
-
Short-container-title:Neurol. Res. Pract.
Author:
Mügge F.,Kleinholdermann U.,Heun A.,Ollenschläger M.,Hannink J.,Pedrosa D. J.
Abstract
Abstract
Background
Mobile gait sensors represent a compelling tool to objectify the severity of symptoms in patients with idiopathic Parkinson’s disease (iPD), but also to determine the therapeutic benefit of interventions. In particular, parameters of Deep Brain stimulation (DBS) with its short latency could be accurately assessed using sensor data. This study aimed at gaining insight into gait changes due to different DBS parameters in patients with subthalamic nucleus (STN) DBS.
Methods
An analysis of various gait examinations was performed on 23 of the initially enrolled 27 iPD patients with chronic STN DBS. Stimulation settings were previously adjusted for either amplitude, frequency, or pulse width in a randomised order. A linear mixed effects model was used to analyse changes in gait speed, stride length, and maximum sensor lift.
Results
The findings of our study indicate significant improvements in gait speed, stride length, and leg lift measurable with mobile gait sensors under different DBS parameter variations. Notably, we observed positive results at 85 Hz, which proved to be more effective than often applied higher frequencies and that these improvements were traceable across almost all conditions. While pulse widths did produce some improvements in leg lift, they were less well tolerated and had inconsistent effects on some of the gait parameters. Our research suggests that using lower frequencies of DBS may offer a more tolerable and effective approach to enhancing gait in individuals with iPD.
Conclusions
Our results advocate for lower stimulation frequencies for patients who report gait difficulties, especially those who can adapt their DBS settings remotely. They also show that mobile gait sensors could be incorporated into clinical practice in the near future.
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference49 articles.
1. Bratsos, S. P., Karponis, D., & Saleh, S. N. (2018). Efficacy and safety of Deep Brain Stimulation in the treatment of Parkinson’s Disease: A systematic review and Meta-analysis of Randomized controlled trials. Cureus. https://doi.org/10.7759/cureus.3474. 2. Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A. L. (1998). Electrical stimulation of the Subthalamic Nucleus in Advanced Parkinson’s Disease. New England Journal of Medicine, 339(16), 1105–1111. 3. Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., Falk, D., Mehdorn, M., Paschen, S., Maarouf, M., Barbe, M. T., Fink, G. R., Kupsch, A., Gruber, D., Schneider, G. H., & EARLYSTIM Study Group. (2013). Neurostimulation for Parkinson’s disease with early motor complications. The New England Journal of Medicine, 368(7), 610–622. 4. Hacker, M. L., Turchan, M., Heusinkveld, L. E., Currie, A. D., Millan, S. H., Molinari, A. L., Konrad, P. E., Davis, T. L., Phibbs, F. T., Hedera, P., Cannard, K. R., Wang, L., & Charles, D. (2020). Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes. Neurology, 95(4), e393–e401. 5. Kremer, N. I., Pauwels, R. W. J., Pozzi, N. G., Lange, F., Roothans, J., Volkmann, J., & Reich, M. M. (2021). Deep brain stimulation for Tremor: Update on long-term outcomes, target considerations and future directions. Journal of Clinical Medicine, 10(16), 3468.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|